Sarah Bos

78 CHAPTER 5 References 1. Lisman T, Leebeek FWG, De Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37(2):280–7. 2. Romano F, Garancini M, Uggeri F, Degrate L, Nespoli L, Gianotti L, et al. Bleeding in hepatic surgery: Sorting through methods to prevent it. HPB Surg. 2012;2012. 3. Bismuth H, Castaing D, Garden JO. Major hepatic resection under total vascular exclusion. Ann Surg. 1989;(07):13–9. 4. De Boer MT, Molenaar IQ, Hendriks HGD, Slooff MJH, Porte RJ. Minimizing blood loss in liver transplantation: Progress through research and evolution of techniques. Dig Surg. 2005;22(4):265–75. 5. Westerkamp AC, Lisman T, Porte RJ. How to minimize blood loss during liver surgery in patient with cirrhosis. Hpb. 2009;11(6):453–8. 6. Reddy SK, Turley RS, Barbas AS, Steel JL, Tsung A, Marsh JW, et al. Post-Operative Pharmacologic Thromboprophylaxis after Major Hepatectomy. J Gastrointest Surg. 2011;15(9):1602–10. 7. Davidson BR, Gibson M, Dick R, Burroughs A, Rolles K. Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation. Transplantation. 1994 Apr 27;57(8):1174–7. 8. Ghabril M, Agarwal S, Lacerda M, Chalasani N, Kwo P, Tector AJ. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors andOutcomes for Portal Vein Thrombosis inWaitlistedPatients. Transplantation. 2016;100(1):126–33. 9. Lisman T, Porte RJ. Value of Preoperative Hemostasis Testing in Patients with Liver Disease for Perioperative Hemostatic Management. Anesthesiology. 2017;126(2):338– 44. 10. Hugenholtz GCG, Northup PG, Porte RJ, Lisman T. Is there a rationale for treatment of chronic liver disease with antithrombotic therapy? Blood Rev. 2015;29(2):127–36. 11. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147–56. 12. Tripodi A. Liver Disease and Hemostatic (Dys) function. Semin Thromb Hemost. 2015;41(5):462–7. 13. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease : evidence and clinical consequences. Blood. 2010;116(6):878–85. 14. Feltracco P, Barbieri S, Cillo U, Zanus G, Senzolo M, Ori C. Perioperative thrombotic complications in liver transplantation. World J Gastroenterol. 2015;8004–13. 15. Hartmann M, Szalai C. Hemostasis in liver transplantation: Pathophysiology, monitoring , and treatment. World J Gastroenterol. 2016; 16. Yoshizumi T, Itoh S, Imai D, Ikegami T, Ninomiya M, Iguchi T, et al. Impact of platelets and serotonin on liver regeneration after living donor hepatectomy. Transplant Proc. 2015;47(3):683–5. 17. Lesurtel M, Raptis DA, Melloul E, Schlegel A, Oberkofler C, El-Badry AM, et al. Low platelet counts after liver transplantation predict early posttransplant survival: the 60-5 criterion. Liver Transpl. 2014;20(2):147–55.